Deep Tech Startups

Vista Innotech develops anti-shaking technology and micro gimbal stabilizers for mobile devices to improve image capture quality. The company serves mobile device manufacturers with patented mechanical, electronic, and optical designs coupled with advanced control software.

1 investor

VistaraBio provides research tools and services for drug discovery, including modified protein assays, post-translationally modified protein catalogs, and cell screening platforms using bioactive peptides. The company serves pharmaceutical and biotech researchers developing small molecule and protein degrader therapeutics.

1 investor

VitalPath designs and manufactures complex catheters and precision laser components for medical device OEMs, offering rapid prototyping and full-scale production in ISO-certified cleanroom facilities. The company serves customers across cardiology, neurology, and peripheral vascular markets with vertically integrated capabilities from design through finished device assembly.

1 investor

Mycronic provides optical inspection equipment and SMT assembly solutions for electronics manufacturers producing PCB assemblies. The company offers automated optical inspection, solder paste inspection, pick-and-place machines, and process control software.

1 investor

Vitro3D develops Parallax Volumetric Additive Manufacturing (P-VAM) technology for production-scale manufacturing, enabling faster and more complex 3D printing without layers, supports, or print farms. The system integrates directly into existing assembly lines to bring additive manufacturing from prototyping to serial production.

1 investor

Vitroprobe Analytics develops a patented biomolecular analysis method using Atom Probe Tomography to examine drug targets and their interactions at near-atomic resolution, helping pharmaceutical developers design and fine-tune new drugs. The company works in collaboration with academia and industry and originated from research at Chalmers University of Technology.

1 investor

Vitroscope develops products and solutions that combine scientific expertise with product development capabilities, supported by advisors from leading research institutions. The company focuses on immunology and cell models based on its advisory team's expertise.

1 investor

VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.

1 investor

AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.

1 investor

Vivere is an early-stage biotech developing cancer therapies that use a bioengineering platform (based on UC Berkeley research) to activate the immune system against "cold" solid tumors through targeted delivery. It focuses on immuno-oncology and gene/viral vector engineering to treat difficult solid cancers.

1 investor

Vividye develops sustainable pigments and dyes that eliminate harmful chemicals and microplastics from the color production process. The company serves industries requiring high-performance colorants while reducing environmental contamination and health risks.

1 investor

Vivtex is a drug development company applying computational science and pre-clinical research to advance new medicines. It operates in the biotech/therapeutics space, working on drug development and related laboratory research.

1 investor

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples. The company serves research and diagnostic laboratories in the life sciences and precision oncology fields.

1 investor

VizionCraFFt develops an AI-powered wearable device designed to enhance mobility and independence for blind and visually impaired users. The device integrates spatial awareness, image recognition, and voice control to provide real-time navigation and environmental information.

1 investor

A railway research institute conducting testing, certification, and technology development for rail infrastructure, traction rolling stock, and high-speed rail. It works across areas including track infrastructure, wagon systems, materials science, and digital transformation.

1 investor

Vocsens develops a gas sensor product called Envicam-30 that uses semiconductor technology with ultra-low power consumption and a matrix of 16 sensing material spots, addressing the cost and maintenance challenges of traditional gas sensing systems.

1 investor

Voice Print provides forensic speaker comparison, speech and audio analysis, and expert witness testimony for Swedish authorities, combining clinical speech-language pathology assessment with acoustic signal analysis and machine learning. It is a research company partly owned by Lund University's holding company LU Ventures and is developing Vocal Studio, a voice and speech recording and analysis platform for clinical and professional users.

1 investor

VoiceEye develops a proprietary 2D barcode technology with high data storage density, using it for internet-based certificate issuance (combined with PKI) and for text-to-speech "VOICEYE" codes that let blind and low-vision people access printed document information. The company serves government, education, insurance, and accessibility markets in South Korea and through dealer agreements across 12 countries.

1 investor

Volatile AI develops custom portable instruments for volatile organic compound (VOC) fingerprinting and gas chromatography. Its technology is applied to use cases such as benzene/BTEX detection, plant pest detection, biopharmaceutical fermentation monitoring, asphalt variant profiling, and whiskey maturation monitoring.

1 investor

Voler Systems publishes a podcast featuring conversations with industry leaders about engineering innovation, product development, and technologies for next-generation devices.

1 investor

Volta provides AI infrastructure services designed to make computational resources as reliable and accessible as electricity for organizations. The company treats compute as essential infrastructure financed and operated through traditional infrastructure financing models.

1 investor

Voltela builds VC2, a cellular command-and-control (C2) link for drones that transmits over the network's emergency-voice channel to gain priority queueing, guaranteed bitrate, and wide coverage. It targets commercial beyond-visual-line-of-sight (BVLOS) drone operators such as inspection and urban delivery services, offered as software or on the VOX carrier board.

1 investor

Volumes captures spatiotemporal (4D) data of real-world objects and environments in motion to create accurate, licensable datasets for AI laboratories. The company transforms physical reality into ground-truth data that enables AI systems to understand spatial relationships, geometry, temporal dynamics, and physical interactions.

1 investor

Volumina Medical develops advanced biomaterial technologies for soft-tissue regeneration and restoration. The company translates scientific discoveries from material science and engineering into minimally invasive medical solutions for clinical use.

1 investor